<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18011">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02872415</url>
  </required_header>
  <id_info>
    <org_study_id>2016-18</org_study_id>
    <secondary_id>2016-A01349-42</secondary_id>
    <nct_id>NCT02872415</nct_id>
  </id_info>
  <brief_title>Effect of Site on Pain in Preterm Neonates</brief_title>
  <acronym>NOBOBO</acronym>
  <official_title>Impact of Alternative Blood Glucose Testing Site (Forearm) on Pain Reduction in Preterm Neonates.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Numerous experimental and clinical studies have shown that preterm neonates are particularly
      sensitive to stress. Preterm neonates routinely undergo painful invasive procedures. Each
      situation causing pain or discomfort can alter their development and cause short term
      cardiovascular consequences but also have long-term neurocognitive influences. Repetitive
      procedural pain can also lead to changes in the pain sensitivity threshold therefore. The
      most common painful procedures are lancing for blood glucose testing. In adults, infants and
      term newborns, forearm blood glucose testing has been demonstrated to be less painful than
      conventional sites (heel, fingers). But data is lacking in preterm neonates.

      The primary purpose of this study is to demonstrate a significant reduction in pain response
      during forearm blood lancing vs conventional sites (fingers, heel) in preterm neonates born
      up to 32 weeks gestation.

      This study is an interventional multicenter (3 centers), randomized, double bind trial with
      a cross over assignment. 60 premature neonates born between 23 to 32 weeks.

      Gestation with a postnatal age less than 72 hours that will undergo at least 3 blood glucose
      pricks will be included. The different sites will be randomly successively tested.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The pain assessment</measure>
    <time_frame>12 months</time_frame>
    <description>Painful response using Premature Infant Pain Profile (PIPP)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Great Premature Newborn</condition>
  <arm_group>
    <arm_group_label>The forearm as blood puncture site</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The child receives a puncture blood on the forearm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fingers like blood puncture site</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Premature receiving a puncture blood on the finger</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood puncture site</intervention_name>
    <arm_group_label>The forearm as blood puncture site</arm_group_label>
    <arm_group_label>Fingers like blood puncture site</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premature neonates 23 to 32 weeks gestation

          -  Infant born with a postnatal age greater than or equal to 3 hours and less or equal
             to 72 hours

          -  Infant born with at least 3 blood glucose testing in less than 72 hours

        Exclusion Criteria:

          -  Severe congenital anomalies that could alter pain perception or expression

          -  Extremities congenital anomaly impeding blood glucose testing on different sites

          -  Infants born to mothers known to be receiving opiates

          -  Severe haemodynamic disturb

          -  Severe neurologic injury

          -  Neonate with opioids or sedatives medications

          -  No parental consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>72 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aurelie SAILLE, Coordinator</last_name>
    <phone>0491384043</phone>
    <email>aurelie.saille@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Urielle DESALBRES, Director</last_name>
    <phone>0491382747</phone>
    <email>drci@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique HÃ´pitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aurelie SAILLE, Coordinator</last_name>
      <phone>0491384043</phone>
      <email>aurelie.saille@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle LIGI, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>November 2, 2016</lastchanged_date>
  <firstreceived_date>August 16, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
